203 related articles for article (PubMed ID: 26490291)
1. Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.
Becerra L; Bishop J; Barmettler G; Xie Y; Navratilova E; Porreca F; Borsook D
J Neurophysiol; 2016 Jan; 115(1):208-17. PubMed ID: 26490291
[TBL] [Abstract][Full Text] [Related]
2. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.
Green AL; Gu P; De Felice M; Dodick D; Ossipov MH; Porreca F
Cephalalgia; 2014 Jul; 34(8):594-604. PubMed ID: 24335852
[TBL] [Abstract][Full Text] [Related]
3. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
Navratilova E; Behravesh S; Oyarzo J; Dodick DW; Banerjee P; Porreca F
Cephalalgia; 2020 Aug; 40(9):892-902. PubMed ID: 32615788
[TBL] [Abstract][Full Text] [Related]
4. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan.
Read SJ; Hirst WD; Upton N; Parsons AA
Brain Res; 2001 Feb; 891(1-2):69-77. PubMed ID: 11164810
[TBL] [Abstract][Full Text] [Related]
5. Triptan-induced disruption of trigemino-cortical connectivity.
Kröger IL; May A
Neurology; 2015 May; 84(21):2124-31. PubMed ID: 25948722
[TBL] [Abstract][Full Text] [Related]
6. Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.
Cottier KE; Galloway EA; Calabrese EC; Tome ME; Liktor-Busa E; Kim J; Davis TP; Vanderah TW; Largent-Milnes TM
eNeuro; 2018; 5(4):. PubMed ID: 30073201
[TBL] [Abstract][Full Text] [Related]
7. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
De Felice M; Ossipov MH; Wang R; Dussor G; Lai J; Meng ID; Chichorro J; Andrews JS; Rakhit S; Maddaford S; Dodick D; Porreca F
Brain; 2010 Aug; 133(Pt 8):2475-88. PubMed ID: 20627971
[TBL] [Abstract][Full Text] [Related]
8. Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
Nation KM; Dodick DW; Navratilova E; Porreca F
Cephalalgia; 2019 Apr; 39(5):617-625. PubMed ID: 30286616
[TBL] [Abstract][Full Text] [Related]
9. Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant.
Tang C; Unekawa M; Kitagawa S; Takizawa T; Kayama Y; Nakahara J; Shibata M
Sci Rep; 2020 Jul; 10(1):11408. PubMed ID: 32651400
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an inverse correlation between serotonergic activity and spreading depression propagation in the rat cortex.
Guedes RCA; Araújo MDGR; Verçosa TC; Bion FM; de Sá AL; Pereira A; Abadie-Guedes R
Brain Res; 2017 Oct; 1672():29-34. PubMed ID: 28751192
[TBL] [Abstract][Full Text] [Related]
11. Comment: How do triptans work in migraine?
Goadsby PJ
Neurology; 2015 May; 84(21):2129. PubMed ID: 25948724
[No Abstract] [Full Text] [Related]
12. Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine action for sumatriptan?
Read SJ; Parsons AA
Brain Res; 2000 Jul; 870(1-2):44-53. PubMed ID: 10869500
[TBL] [Abstract][Full Text] [Related]
13. A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA).
Netsiri C; Bradley DP; Takeda T; Smith MI; Papadakis N; Hall LD; Parsons AA; James MF; Huang CL
Magn Reson Imaging; 2003 Nov; 21(9):1097-110. PubMed ID: 14684218
[TBL] [Abstract][Full Text] [Related]
14. Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats.
Kandasamy R; Lee AT; Morgan MM
J Headache Pain; 2017 Dec; 18(1):5. PubMed ID: 28091820
[TBL] [Abstract][Full Text] [Related]
15. Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues.
Knapp L; Szita B; Kocsis K; Vécsei L; Toldi J
Drug Des Devel Ther; 2017; 11():27-34. PubMed ID: 28053504
[TBL] [Abstract][Full Text] [Related]
16. Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice.
Lionetto L; Negro A; Casolla B; Simmaco M; Martelletti P
Expert Opin Pharmacother; 2012 Nov; 13(16):2369-80. PubMed ID: 23013035
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain.
Dobson CF; Tohyama Y; Diksic M; Hamel E
Cephalalgia; 2004 Jan; 24(1):2-11. PubMed ID: 14687006
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersat.
Bradley DP; Smith MI; Netsiri C; Smith JM; Bockhorst KH; Hall LD; Huang CL; Leslie RA; Parsons AA; James MF
Exp Neurol; 2001 Dec; 172(2):342-53. PubMed ID: 11716558
[TBL] [Abstract][Full Text] [Related]
20. The complex actions of sumatriptan on rat dural afferents.
Harriott AM; Scheff NN; Gold MS
Cephalalgia; 2012 Jul; 32(10):738-49. PubMed ID: 22711897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
